Discovery of severe pneumonia subtypes could lead to tailored treatments for life-threating disease | University of Cambridge
Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study at Cambridge
About the University
Research at Cambridge
Quick links
For Cambridge students
For staff
For alumni
For our<br>researchers
Business and<br>enterprise
Colleges &<br>departments
Give to Cambridge
Libraries
Museums & collections
Search site
Home
Study at Cambridge
Undergraduate
Undergraduate courses
Applying
Events and open days
Fees and finance
Postgraduate
Postgraduate courses
How to apply
Postgraduate events
Fees and funding
International<br>students
Continuing education
Executive and professional education
Courses in education
About the University
How the<br>University and Colleges work
Term dates and calendars
History
Map
Visiting the University
News
Annual reports
A global university
Equality and diversity
Events
Public engagement
Jobs
Give to Cambridge
Research at Cambridge
For staff
For Cambridge students
For alumni
For our researchers
Business and enterprise
Colleges & departments
Email & phone search
Give to Cambridge
Libraries
Museums & collections
Discovery of severe pneumonia subtypes could lead to tailored treatments for life-threating disease
Cambridge researchers have shown that severe pneumonia has three different subtypes, helping explain why some patients in intensive care units (ICUs) recover from their illness faster than others, while for other patients the disease can be life-threatening.
The current approach of classifying patients by their clinical syndromes without looking at the underlying biology risks missing what’s key
Andrew Conway Morris
Their findings could in future help inform tailored treatments, allowing individual patients to receive the most appropriate therapies.<br>Pneumonia is the commonest infectious cause of death worldwide, responsible for an estimated 2.5 million deaths per year. In severe cases, patients may need to be admitted to an ICU and given mechanical ventilation. Severe pneumonia accounts for six in 10 infections managed in intensive care, and spread of the infection within ICUs is a significant concern.<br>Doctors have long struggled to understand why patients whose condition looks similar clinically can have very different recoveries. Some respond quickly to treatment, while others remain critically ill for weeks or even die.<br>Dr Andrew Conway Morris from the Department of Medicine at the University of Cambridge and an ICU consultant at Addenbrooke’s Hospital, Cambridge, said: “Even though we’re able to treat the initial infection, many patients with severe pneumonia still struggle to come off the ventilator and can develop lung failure. Therapies to tackle inflammation in the lungs have had mixed results in clinical trials – some suggest they are beneficial, others that they're harmful.<br>“The current approach of classifying patients by their clinical syndromes – sepsis, acute respiratory distress syndrome and so on – without looking at the underlying biology risks missing what’s key. Instead of asking ‘Does this patient have pneumonia?’, we should be asking ‘What's the inflammatory pattern in this patient's lungs?’”<br>In findings published today in Nature Communications, Professor Conway Morris and team recruited patients admitted with suspected severe pneumonia to the ICU at Addenbrooke’s Hospital, part of Cambridge University Hospitals NHS Foundation Trust.<br>Severe pneumonia is usually diagnosed through a combination of symptoms, imaging and blood tests. Symptoms typically include fever or hypothermia, low oxygen levels, breathing difficulties and confusion.<br>Instead of relying only on blood tests or scans, however, the Cambridge team analysed immune cells, inflammatory signals, and gene activity in fluid taken from the lungs of the patients. They discovered that there are three distinct biological types – or ‘pneumotypes’ – of severe pneumonia, none of which could be reliably detected using standard blood tests, even though they were strongly linked to how patients recovered.<br>The most common pneumotype – accounting for almost half (49%) of cases – was characterised by immune suppression, significant damage to the lining of the lungs, and bleeding in the alveoli (tiny air sacs within the lungs). There were fewer signs of inflammation, which may explain why treatments targeting inflammation can fail or even harm some patients.<br>The second pneumotype – accounting for just under a quarter (23%) of cases – was characterised by a balanced immune response and active repair of damage to the lungs. Patients were most likely to recover faster from this pneumotype and require the shortest time on the ventilator, even though they initially looked just as ill as the others.<br>Patients with the most dangerous pneumotype – the one that most resembles ‘classic’ pneumonia – spent longest on mechanical ventilation...